COVID-19 et assistance circulatoire

Hékimian, Guillaume; Frère, Corinne; Collet, Jean Philippe

doi:10.1016/j.ancard.2020.10.004

Cited by 4 publications

(1 citation statement)

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In line with Gattioni et al (2020), in the study by Grasselli et al (2020), it was seen that ARDS is a complication of COVID-19, which was diagnosed in 40% to 96% of ICU patients. the protective strategy as a treatment for severe hypoxemia resulting from the most severe forms of ARDS, which is responsible for 40 to 50% of mortality (HEKIMIAN, FRERE & COLLET, 2020).…”

Section: Resultsmentioning

confidence: 99%

Analysis of Mechanical Ventilatory Assistance Protocols in Patients With Covid-19: An Integrative Literature Review

Brandão¹,

Barbosa²,

Ramalho³

et al. 2022

JHS

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Analysis of Mechanical Ventilatory Assistance Protocols in Patients With Covid-19: An Integrative Literature Review

Brandão¹,

Barbosa²,

Ramalho³

et al. 2022

JHS

View full text Add to dashboard Cite

La télémédecine et les réseaux sociaux dans la gestion des ECMO à l’ère de COVID-19 : l’expérience Tunisienne

Mleyhi

Ziadi

Hmida

et al. 2021

Annales de Cardiologie et d'Angéiologie

View full text Add to dashboard Cite

Multisystem inflammatory syndrome-related refractory cardiogenic shock in adults after coronavirus disease 2019 infection: a case series

Tonon¹,

Landrieux²,

Plas³

et al. 2022

European Heart Journal - Case Reports

View full text Add to dashboard Cite

Background A novel multisystem inflammatory syndrome in children (MIS-C) temporally associated with the coronavirus disease 2019 (COVID-19) infection has been reported, arising weeks after the peak incidence of COVID-19 infection in adults. Patients with MIS-C have been reported to have cardiac involvement and clinical features overlapping with other acute inflammatory syndromes such as Kawasaki-Disease, toxic shock syndrome, and macrophage activation syndrome. MIS-C may follow Covid-19 infection, most of the time after its asymptomatic form, even though it can lead to serious and life-threatening illness. Case summary In this case series, we discuss two cases of young adults with no former medical history who fit with the criteria defined in MIS-C. They both developed a refractory cardiogenic shock and required intensive care treatment including mechanical circulatory support, specifically the use of venous-arterial extracorporeal membrane oxygenation (VA-ECMO). They were both treated early with intravenous immune globulin and adjunctive high-dose steroids. They recovered ad integrum in less than two weeks. Discussion MIS-C occurs 2 to 4 weeks after infection with SARS-CoV-2. Patients with MIS-C should ideally be managed in an intensive care environment since rapid clinical deterioration may occur. It would be preferable to have a multi-disciplinary care to improve outcomes. Patients should be monitored for shock. Elucidating the mechanism of this new entity may have importance for understanding COVID-19 far beyond the patients who have had MIS-C to date. The pathogenesis seems to involve post-infectious immune dysregulation so early administration intravenous immune globulin associated to corticosteroids appears appropriate. It implies early recognition of the syndrome even in young adults.

show abstract

COVID-19 et assistance circulatoire

Cited by 4 publications

References 50 publications

Analysis of Mechanical Ventilatory Assistance Protocols in Patients With Covid-19: An Integrative Literature Review

Analysis of Mechanical Ventilatory Assistance Protocols in Patients With Covid-19: An Integrative Literature Review

La télémédecine et les réseaux sociaux dans la gestion des ECMO à l’ère de COVID-19 : l’expérience Tunisienne

Multisystem inflammatory syndrome-related refractory cardiogenic shock in adults after coronavirus disease 2019 infection: a case series

Contact Info

Product

Resources

About